Search
Returning search results with filters:
Remove filter for
Category: Health product
Remove filter for
Last updated: 2009
Clear all
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 3 of 3 items.
Archived - Drug Release Information for the EVRA Transdermal Contraceptive System - For the Public
… Starting date: March 19, 2009 Posting date: March 19, 2009 Type of communication: … RA-19000741 This is duplicated text of a letter from Janssen-Ortho Inc. Contact the company for a copy of any … Footnote * Birth Control Patch Average Daily Release Rate Janssen-Ortho Inc., in cooperation with Health Canada, is …
AlertHealth professional risk communication | 2009-03-19
Archived – New Safety Information Regarding Intelence (etravirine) and Severe Skin and Hypersensitivity Reactions – For the Public
… Starting date: October 19, 2009 Posting date: October 19, 2009 Type of … is duplicated text of a letter from Tibotec, a division of Janssen-Ortho Inc . Contact the company for a copy of any … Severe Skin and Allergic Reactions Tibotec, a division of Janssen-Ortho Inc. ("Tibotec"), in collaboration with Health …
AlertHealth professional risk communication | 2009-10-19
New Safety Information Regarding Intelence (etravirine) and Severe Skin and Hypersensitivity Reactions - For Health Professionals
… Starting date: October 15, 2009 Posting date: October 19, 2009 Type of communication: Dear Healthcare Professional … is duplicated text of a letter from Tibotec, a division of Janssen-Ortho Inc. Contact the company for a copy of any … Dear Health Care Professional, Tibotec, a division of Janssen-Ortho Inc. ("Tibotec"), in collaboration with Health …
AlertHealth professional risk communication | 2009-10-19